You are using an older browser version. Please use a supported version for the best MSN experience.

AstraZeneca's EVP on the potential of the pharma giant's new breast cancer drug

AstraZeneca Executive Vice-President of the Oncology Business Unit David Fredrickson discusses the drugmaker's Enhertu breast cancer drug trial results.
image beaconimage beaconimage beacon